NASPAG, like many other major medical organizations, has been disheartened to see limitations placed on the provision of sexual health education to our youth. Comprehensive sexuality education has been shown to better prepare young persons to make informed and healthy decision about their sexual health and sexual health behaviors. In support of the provision of unrestricted, evidence based comprehensive sexual health education to our youth, the NASPAG Advocacy Committee has released a position statement.

Click Here to Read the Full Statement

Exclusive Discount for NASPAG Members




Judith Simms-Cendan, President [email protected]
Brent Schwartz, Executive Director [email protected]

Welcome to NASPAG! 

Whether you are a decades-long NASPAG supporter, a colleague looking for support in caring for your patient, a student learning about pediatric gynecology for the first time,  or anything in between, we are glad you are here! NASPAG is an incredibly vibrant organization filled with members dedicated to improving the reproductive health of youth through evidence-based clinical care, advocacy, education, and research. Our annual meeting energizes us (see you April 4-6 in Orlando), but we know this website is where you need to come to connect and find helpful resources the rest of the year, so welcome! 

I am incredibly grateful for the opportunity to serve NASPAG as president this year. Together with our awesome board, teams of experts in research, finance, education and advocacy, and with support from Brent Schwartz and our Talley team, we will be working to strengthen NASPAGs support of its stakeholders-members, learners, the pediatric adolescent patient, and the organization itself. If you have ideas, please reach out to me! 

With warmest regards, 

Judy Simms-Cendan, MD
[email protected]
NASPAG President 2023-24




This Tuesday, May 9th, NASPAG was one of 37 different organizations and/or individuals to speak at the Open Public Hearing session of the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee of the FDA. The Advisory Committee was assembled to review the application from HRA Pharma for a "prescription-to-OTC" switch for Norgestrel 0.075mg (Opill) as a progestin-only oral contraceptive. Speakers included several major medical societies, reproductive justice and advocacy organizations, and many youth who boldly shared their personal stories! Out of the 37 speakers, 35 spoke in strong support of the proposal. 

Read More 

Read Full Statement


ACOG Message


Talking points - COVID-19 Vaccine and Reproductive Health:

With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.

Click here to read more

 NASPAG'S Response to Texas Senate Bill 8

NASPAG’s mission is to advocate for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased, and evidence-based practice of Pediatric and Adolescent Gynecology. The Texas Senate Bill 8 undermines the ability of Pediatric and Adolescent health care providers to align with NASPAG’s mission. This bill impacts critical reproductive health care, which undoubtedly will disproportionately impact those with poorest resources and access to care. This is one of the most restrictive abortions bans in the US, making abortion illegal with no exceptions for rape, sexual abuse, incest, or fetal anomaly diagnosis.  
Click here to read more